Back | Next |
home / stock / enta / enta message board
Subject | By | Source | When |
---|---|---|---|
$ENTA where is the squeeze? | willyw | investorshub | 05/03/2023 4:22:06 PM |
$ENTA great news | Jake2234 | investorshub | 05/03/2023 1:08:57 PM |
$ENTA MomentumIts now | rwwine | investorshub | 05/03/2023 11:05:09 AM |
$ENTA best news of the day | vinmantoo | investorshub | 05/03/2023 12:52:45 AM |
The last few days have been a nice | Rocky3 | investorshub | 05/02/2023 8:18:36 PM |
Thank you Vin! Hoping it doesnt run | randychub | investorshub | 05/02/2023 6:22:06 PM |
Is the EDP-235 phase 2 designed to show | vinmantoo | investorshub | 05/02/2023 3:35:20 PM |
I don't have any info on the timeline | DewDiligence | investorshub | 05/02/2023 3:04:46 PM |
Re $ENTA's patent suit against Pfizer. | LongRun8 | investorshub | 05/02/2023 2:41:45 PM |
Indeed, yes. | Jake2234 | investorshub | 05/02/2023 2:16:56 PM |
Is the EDP-235 phase 2 designed to show | randychub | investorshub | 05/02/2023 12:28:13 PM |
The last few days have been a nice | vinmantoo | investorshub | 05/02/2023 2:24:29 AM |
short squeeze all day | Jake2234 | investorshub | 05/02/2023 12:36:04 AM |
$ENTA updated corporate slide set (4/18/23): | DewDiligence | investorshub | 04/29/2023 6:30:47 PM |
It is obvious to anyone with a functioning | vinmantoo | investorshub | 04/29/2023 5:18:54 PM |
$ENTA Price trading | vinmantoo | investorshub | 04/29/2023 3:01:28 PM |
The angry dog barks, but the caravan moves on. | vinmantoo | investorshub | 04/27/2023 8:48:22 PM |
Everything used to be about NASH. Tanked. Then | Jake2234 | investorshub | 04/27/2023 8:24:37 PM |
Much Lower than average volume on no news | vinmantoo | investorshub | 04/27/2023 8:23:55 PM |
Id advise against it. Suggest you read between | Jake2234 | investorshub | 04/27/2023 8:01:54 PM |
News, Short Squeeze, Breakout and More Instantly...
Enanta Pharmaceuticals Inc. Company Name:
ENTA Stock Symbol:
NASDAQ Market:
Enanta Pharmaceuticals Inc. Website:
2024-04-21 03:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for indications in virology and immunology, today announced that data from the company’s SPRINT ( S ARS-Cov-2 PR otease IN hibitor T reatment) stu...
2024-03-22 05:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...